NCT06838936

Brief Summary

The research is a randomized controlled trial. The sample group will consist of 120 people; 60 participants will be included in the experimental group, and 60 will be included in the control group. In the study, the participants in the experimental group will listen to the alpha sound for pain for 10 minutes and the delta sound for sleep for 15 minutes via the mobile application three days a week. The researchers will not intervene with the control group during the study. During the study, only the data collection tabs of the mobile application will be active for the control group, and the use of the sounds will be opened at the end of the study. The study data were used in the personal identification form, menstruation symptom scale, Pittsburgh sleep quality index, and Women's Health Initiative Insomnia Scale.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 19, 2025

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 21, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2025

Completed
Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

2 months

First QC Date

January 19, 2025

Last Update Submit

June 30, 2025

Conditions

Keywords

dysmenorrhea primarypainsleep qualitybinaural beats

Outcome Measures

Primary Outcomes (4)

  • Numeric Rating Scale

    The Numerical Pain Scale is the most commonly used and easiest to measure scale for pain assessment. No pain is given 0 (zero), and unbearable pain is given 10 (ten) points.

    up to six months

  • Menstrual Symptom Questionnaire

    It was developed by Chesney and Tasto in 1975 to assess menstrual pain and symptoms. The scale, which is a five-point Likert type and consists of 24 items, was updated by Negriff et al. in 2009. The MSÖ score is calculated by taking the total score average of the items in the scale. An increase in the score average indicates that the severity of menstrual symptoms increases. The scale consists of 22 items and a total of three sub-dimensions. On the scale, participants give a value between one and five (1=never, 2=sometimes, 3=occasionally, 4=often, 5=always) to the symptoms they experience related to menstruation. The score obtained from the sub-dimensions in the scale is calculated by taking the total score average of the items in the sub-dimensions. An increase in the scoring average for the sub-dimensions indicates that the severity of menstrual symptoms related to that sub-dimension increases.

    up to six months

  • Pittsburgh Sleep Quality Index

    The Pittsburgh Sleep Quality Index was developed in 1988 to determine sleep quality. It consists of 7 components with a total of 24 questions. These components are subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping pills and daytime dysfunction. The sum of the scores of all components gives the PSQI score. The 10th and 11th questions in the index are not included in the calculation. Scores of 5 and above indicate poor sleep quality, and as the score received on the scale increases, sleep quality worsens. The index was studied for reliability and validity by Ağargün et al (1996) and its internal consistency was found to be 0.80.

    up to six months

  • Women's Health Initiative Insomnia Scale

    The validity and reliability study of the scale developed by Levine et al. (2003) was conducted in our country by Timur and Şahin (2009). The scale is a Likert-type scale consisting of 5 questions. The first four questions in the scale determine the onset of insomnia, inability to maintain sleep, and early morning awakening. The last question is related to sleep quality. The answer to each question is based on the individual's experiences in the last 4 weeks and considering the frequency of each week.

    up to six months

Study Arms (2)

Interventional group

EXPERIMENTAL

Mobil application (binaural beats)

Other: Binaural Beats

Control group

NO INTERVENTION

Control group

Interventions

Mobile application for binaural beats listening

Interventional group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with primary dysmenorrhea
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over 18 years old
  • Having headphones (for the experimental group)
  • Having pain of 4 and above according to the numerical pain scale
  • Taking a Women's Health and Diseases Nursing Course
  • Not using medication during menstruation
  • Not using sleeping pills
  • Being single
  • Not using contraceptives
  • Not having a hearing problem
  • Not having a psychiatric problem

You may not qualify if:

  • Not listening to binaural sounds for two days or more on the days specified in the mobile application
  • Using analgesics during menstruation while the study is ongoing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inonu University

Malatya, Malatya, 44280, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be determined blindly by being assigned by a site
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Our study has two groups of 60 participiants each group. Our study is an experimental study with pretest-posttest control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research assistant

Study Record Dates

First Submitted

January 19, 2025

First Posted

February 21, 2025

Study Start

November 30, 2024

Primary Completion

January 30, 2025

Study Completion

May 15, 2025

Last Updated

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Indivual participant data (IPD) will not be avaliable to other researchers, they will be kept secret.

Locations